Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Vaxon Biotech
DescriptionVaccine containing optimized cryptic polypeptide which targets three peptides in major histocompatibility complex (MHC) class I A2 (HLA-A2) patients
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationGastric cancer
Indication DetailsTreat gastric cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today